Lipoxin A4

CAS No. 89663-86-5

Lipoxin A4( —— )

Catalog No. M34814 CAS No. 89663-86-5

Lipoxin A4 (LXA4) is a lipoxygenase-derived arachidonate-like mediator with anti-inflammatory properties.Lipoxin A4 attenuates MSU crystal-induced NLRP3 inflammasome activation through inhibition of Nrf2, and regulates M1/M2 macrophage polarization through the FPR2-IRF pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lipoxin A4
  • Note
    Research use only, not for human use.
  • Brief Description
    Lipoxin A4 (LXA4) is a lipoxygenase-derived arachidonate-like mediator with anti-inflammatory properties.Lipoxin A4 attenuates MSU crystal-induced NLRP3 inflammasome activation through inhibition of Nrf2, and regulates M1/M2 macrophage polarization through the FPR2-IRF pathway.
  • Description
    Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.
  • In Vitro
    Lipoxin A4 (LXA4) inhibits the expression of IL-6 and IL-8 in NHEKs. Lipoxin A4 downregulates the expression of cyclin D1.Lipoxin A4 also suppresses the ERK1/2 phosphorylation and NF-kB-p65 nuclear translocation of NHEKs.LXA4 (100 nM; preincubation for 30 minutes)inhibits the proliferation of NHEKs with or without stimulating by LPS (10 μg/mL). LXA4 pretreatment (100? nM for 30?minutes) downregulates the LPS-induced secretion and expression of HMGB1 in keratinocytes.Cell Proliferation Assay Cell Line:Normal human epidermal keratinocytes (NHEKs) Concentration:100 nM Incubation Time:30 minutes Result:A significant increase in proliferation of NHEKs after 7 days of stimulation with LPS (10 μg/mL) was seen. However, there was a significant decrease in the proliferation of NHEKs when pretreated with LXA4 for 30 min. Western Blot Analysis Cell Line:Normal human epidermal keratinocytes (NHEKs) Concentration:100?nM Incubation Time:30?minutes.Result:HMGB1 protein levels in the cytoplasm of NHEKs were induced by LPS, which were decreased after preincubation with LXA4 but decreased in the nucleus after stimulation with LPS.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite | Interleukin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89663-86-5
  • Formula Weight
    352.47
  • Molecular Formula
    C20H32O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H]([C@H](CCCC(O)=O)O)(/C=C/C=C/C=C\C=C\[C@H](CCCCC)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Feng Hu, et al. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways. J Dermatol Sci. 2015 Jun;78(3):181-8.?
molnova catalog
related products
  • 17-DIMETHYLXANTHINE

    Paraxanthine is a metabolite of caffeine (sc-202514) which functions as an adenosine receptor ligand and a PARP-1 inhibitor in pulmonary epithelial cells.

  • Norgestimate metabol...

    Norelgestromin is one of the active metabolites of norgestimate.It is a steroidal progestin used in contraceptive patches, where it is combined with the estrogen ethinyl estradiol.

  • Oxaloacetic acid

    Oxaloacetic acid also known as oxosuccinic acid or oxalacetic acid is a four-carbon dicarboxylic acid appearing as an intermediate of the citric acid cycle.